Mycobacterium tuberculosis cell wall virulence factors
Mycobacterium tuberculosis cell wall virulence factors
批准号:
6750066
负责人:
Susan E Dorman
金额:
$7.86万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-06-01 至 2006-05-31
关键词:
Mycobacterium tuberculosisapoptosisbacteria infection mechanismbacterial geneticscell component structure /functioncell linecell wallcytokineenzyme linked immunosorbent assayflow cytometryhost organism interactionimmunoregulationimmunosuppressioninterferon gammamacrophagemicroorganism culturemicroorganism metabolismmutantterminal nick end labelingtoll like receptortransposon /insertion elementtuberculosisvirulence
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Tuberculosis (TB) kills approximately 3 million people per year. An important characteristic of M. tuberculosis is its ability to survive within human macrophages, and mycobacterial cell wall components are plausible mediators of this effect. However, little is known about the role of specific cell wall components in either mycobacterial survival within host macrophages or modulation of macrophage responses to mycobacterial infection. In our laboratory, the recent generation of a M. tuberculosis transposon-mediated mutant library provides a unique opportunity to systematically investigate these issues. Our overall objective is to understand the role of M. tuberculosis cell wall components in the pathogenesis of TB. Our hypothesis is that M. tuberculosis cell wall components modulate macrophage immune responses, and that alteration of the cell wall will affect macrophage responses to mycobacteria. The specific aim of this R03 proposal is to characterize human macrophage responses to a) infection with M. tuberculosis transposon-mediated mutants predicted to have alterations in the cell wall, and b)stimulation with cell wall fractions from those mutants. Mutants with disruptions in genes known or predicted to be involved in biosynthesis of sulfolipids, lipoarabinomannan, mycolic acids, and phthiocerol dimycocerosate will be used. Host cell cytokine production, chemokine production, apoptosis, IFN gamma-mediated responses, and toll-like receptor-mediated responses will be characterized, and mycobacterial survival and growth within macrophages will be determined. This research will lead to a better understanding of how mycobacterial cell wall components affect bacteria-host cell interactions, and will facilitate identification of new anti-tuberculosis drug targets and vaccine strategies. If cell wall components contribute to M. tuberculosis-induced immune suppression, then evaluation of appropriate mutant strains as vaccines would be warranted. These studies will also serve as a foundation for development of rapid in vitro screening systems to evaluate the effects of other M. tuberculosis genes or cellular components on targeted host immune responses. Finally, new information from the proposed self-contained pilot studies will serve as the foundation for future comprehensive dissection of macrophage response pathways affected by specific cell wall components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics
-
批准号:8891560
-
项目类别:
-
资助金额:$16.03万
-
财政年份:2015
-
负责人:Susan E Dorman
-
依托单位:
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics
-
批准号:9014479
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2015
-
负责人:Susan E Dorman
-
依托单位:
Multidisciplinary Clinical Research and Mentoring in Tuberculosis Diagnostics
-
批准号:9586345
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2015
-
负责人:Susan E Dorman
-
依托单位:
Lipidated Mycobacterium tuberculosis biomarkers in clinical specimens
-
批准号:8583121
-
项目类别:
-
资助金额:$26.32万
-
财政年份:2013
-
负责人:Susan E Dorman
-
依托单位:
Lipidated Mycobacterium tuberculosis biomarkers in clinical specimens
-
批准号:8660620
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Susan E Dorman
-
依托单位:
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0
-
批准号:7567947
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:Susan E Dorman
-
依托单位:
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0
-
批准号:8320752
-
项目类别:
-
资助金额:$38.77万
-
财政年份:2009
-
负责人:Susan E Dorman
-
依托单位:
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0
-
批准号:7753247
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:Susan E Dorman
-
依托单位:
Phase II Study of Daily Rifapentine for Pulmonary Tuberculosis (IND 62,611; 1/2/0
-
批准号:8141454
-
项目类别:
-
资助金额:$40.0万
-
财政年份:2009
-
负责人:Susan E Dorman
-
依托单位:
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
-
批准号:8111830
-
项目类别:
-
资助金额:$66.07万
-
财政年份:2008
-
负责人:Susan E Dorman
-
依托单位:
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
-
批准号:8282771
-
项目类别:
-
资助金额:$68.3万
-
财政年份:2008
-
负责人:Susan E Dorman
-
依托单位:
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
-
批准号:7495347
-
项目类别:
-
资助金额:$66.95万
-
财政年份:2008
-
负责人:Susan E Dorman
-
依托单位:
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
-
批准号:7880859
-
项目类别:
-
资助金额:$60.89万
-
财政年份:2008
-
负责人:Susan E Dorman
-
依托单位:
Extensively Drug-Resistant Tuberculosis Among Gold Miners in South Africa
-
批准号:7640636
-
项目类别:
-
资助金额:$62.05万
-
财政年份:2008
-
负责人:Susan E Dorman
-
依托单位:
Rapid Detection of Mycobacterium tuberculosis
-
批准号:6700212
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2003
-
负责人:Susan E Dorman
-
依托单位:
Rapid Detection of Mycobacterium tuberculosis
-
批准号:6579775
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2003
-
负责人:Susan E Dorman
-
依托单位:
Rapid Detection of Mycobacterium tuberculosis
-
批准号:7009568
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2003
-
负责人:Susan E Dorman
-
依托单位:
Rapid Detection of Mycobacterium tuberculosis
-
批准号:6845169
-
项目类别:
-
资助金额:$13.15万
-
财政年份:2003
-
负责人:Susan E Dorman
-
依托单位:
Mycobacterium tuberculosis cell wall virulence factors
-
批准号:6597330
-
项目类别:
-
资助金额:$7.73万
-
财政年份:2003
-
负责人:Susan E Dorman
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: